199463-20-2 Usage
General Description
4-Chloro-5,6-dimethyl-2-(4-fluorophenylamino)pyrimidine is a chemical compound that belongs to the pyrimidine class of organic compounds. It is a white to off-white solid that is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs and active pharmaceutical ingredients. 4-Chloro-5,6-dimethyl-2-(4-fluorophenylamino)pyrimidine has a molecular formula of C14H13ClF2N4 and a molecular weight of 300.7 g/mol. It is characterized by its chloro, methyl, and fluoro substituents, as well as its pyrimidine and aniline moieties. 4-Chloro-5,6-dimethyl-2-(4-fluorophenylamino)pyrimidine is known for its potential as an antiviral and antitumor agent, and it is commonly used as a reagent in chemical reactions to produce pharmaceuticals for the treatment of various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 199463-20-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,4,6 and 3 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 199463-20:
(8*1)+(7*9)+(6*9)+(5*4)+(4*6)+(3*3)+(2*2)+(1*0)=182
182 % 10 = 2
So 199463-20-2 is a valid CAS Registry Number.
InChI:InChI=1S/C12H11ClFN3/c1-7-8(2)15-12(17-11(7)13)16-10-5-3-9(14)4-6-10/h3-6H,1-2H3,(H,15,16,17)
199463-20-2Relevant articles and documents
Method for preparing revaprzan hydrochloride
-
Paragraph 0056; 0057; 0058, (2018/03/24)
The invention discloses a method for preparing revaprzan hydrochloride (namely revaprazan). According to the method, a phase transfer catalyst is adopted for substitution reactions of key steps, waterand/or a low melting point organic solvent is adopted a
Revaprazan hydrochloride impurities and preparation method thereof
-
Paragraph 0074-0075; 0076-0077; 0078-0079; 0080-0081, (2017/09/01)
The invention provides a compound with a structural formula X as shown in the specification, or a tautomer, mesomer, raceme, enantiomer, diastereomer or mixture thereof, or a pharmaceutically acceptable salt or solvate of the compound with the structural